Incidence and Predictors of Recurrent Stroke in Cryptogenic Stroke Patients With Atrial Fibrillation
1 other identifier
observational
109
1 country
1
Brief Summary
Brief Summary: This study aimed to investigate the risk and factors that predict recurrent stroke in patients who initially had a stroke with no clear cause (called cryptogenic stroke) and were later found to have atrial fibrillation (AF), an irregular heart rhythm that can increase stroke risk. The study was conducted at Lady Reading Hospital in Peshawar, Pakistan, over five years from 2018 to 2023. Stroke is a leading cause of death and disability worldwide. In many cases, the cause of stroke is unclear, which makes it difficult to prevent it from happening again. Atrial fibrillation is a common hidden cause of such strokes but is often hard to detect because it can occur intermittently without symptoms. Detecting AF early is important because patients with AF benefit greatly from blood-thinning medicines (anticoagulants) that reduce the risk of another stroke. In this study, medical records of patients diagnosed with cryptogenic stroke were reviewed. Patients who were later diagnosed with atrial fibrillation within 12 months of their stroke were included. The researchers collected information about their age, gender, heart examinations, how and when AF was diagnosed, use of blood-thinning medicines, and if they had another stroke during follow-up. The study highlights the importance of early and prolonged heart rhythm monitoring in patients with cryptogenic stroke to detect atrial fibrillation. It also stresses the need for better access to and adherence to anticoagulant therapy in resource-limited settings like Pakistan to reduce the risk of recurrent stroke and improve patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
August 10, 2025
CompletedFirst Posted
Study publicly available on registry
August 17, 2025
CompletedAugust 17, 2025
August 1, 2025
6 years
August 10, 2025
August 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Recurrent Ischemic Stroke
Occurrence of new ischemic stroke confirmed by clinical assessment and neuroimaging during the follow-up period in patients initially diagnosed with cryptogenic stroke and later diagnosed with atrial fibrillation.
5 years
Interventions
This observational study involved the use of standard cardiac monitoring methods to detect atrial fibrillation in patients initially diagnosed with cryptogenic ischemic stroke. Monitoring techniques included 12-lead ECG, 24-hour Holter monitoring, and implantable loop recorders (ILRs). No experimental interventions were assigned; patients received routine clinical care.
Eligibility Criteria
This study includes adult patients admitted to Lady Reading Hospital with cryptogenic ischemic stroke who were later diagnosed with atrial fibrillation within 12 months. The cohort was followed for recurrent stroke and clinical outcomes over a median of 13.8 months.
You may qualify if:
- Adults aged 18 years or older.
- Patients initially diagnosed with cryptogenic ischemic stroke confirmed by neuroimaging and standard diagnostic evaluation.
- Patients subsequently diagnosed with atrial fibrillation within 12 months of index stroke, confirmed by ECG, 24-hour Holter monitoring, or implantable loop recorder.
- Availability of complete clinical and follow-up data.
You may not qualify if:
- Known history of atrial fibrillation or atrial flutter prior to the index stroke.
- Presence of structural heart diseases, valvular abnormalities, or congenital cardiac anomalies.
- Incomplete clinical or follow-up data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LRH/MTI
Peshawar, KPK, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
August 10, 2025
First Posted
August 17, 2025
Study Start
January 1, 2018
Primary Completion
December 14, 2023
Study Completion
December 31, 2023
Last Updated
August 17, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share